METABOLIC & ENDO Flashcards

1
Q

Inborn errors of metabolism or inherited metabolic disorders

A
  • single gene mutation
  • ateration of primary proteni
  • compromised or abolished
  • disease states
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

is a common finding in a variety of inborn
errors of metabolism

A

Hepatomegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

An inborn error of metabolism should be considered in any child with 1 or more of the following manifestations:

A
  • Unexplained intellectual disability developmental delay or regression motor deficits or adventitious movements (e.g. dystonia, choreoathetosis) convulsions, unusual odor (particularly during an acute illness)
  • Intermittent episodes of unexplained vomiting acidosis, mental deterioration, psychotic behavior or coma
  • Hepatomegaly, renal stones, muscle weakness, cardiomyopathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The majority of patients with genetic disorders of
metabolism respond to 1 or all of the following
treatments:

A
  • Special diets: plays an important role
  • Hemodialysis: removal of accumulated noxious compounds
  • Catabolic states in patients at risk for metabolic crisis
  • Administration of the deficient metabolite
  • Administration of the cofactor or coenzyme
  • Activation of alternate pathways to reduce the noxious compounds
  • Administration of the deficient enzyme
  • Bone marrow transplantation
  • Liver transplantation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

modalities have the potential to cure the metabolic abnormalities

A

The bone marrow and liver transplantation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
  • Has the most severe clinical manifestations
  • Affected infants who are normal at birth develop
    > poor feeding and vomiting in the 1%t week of life
    > Lethargy and coma may ensue within a few days
  • Physical examination reveals:
    > Hypertonicity
    > Muscular rigidity
    > Severe opisthotonus
    > Hypoglycemia
    > Cerebral edema may be present
    > convulsions occur in most infants
    > Death usually occurs in untreated patients in the first few weeks o months of life
A

Classic Maple Syrup Urine Disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Classical Maple Syrup Urine Disease Diagnosis confirmed by

A
  • marked elevations in plasma levels of leucine, isoleucine, valine, and alloisoleucine (a stereoisomer of isoleucine not normally found in blood) and depression of alanine
  • Leucine levels are usually higher than those of the other 3 amino acids
  • Urine contains high levels of leucine, isoleucine, and valine and their respective ketoacids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

MSUD, The enzyme activity can be measured in

A
  • leukocytes
  • cultured fibroblasts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Treatment of the acute state MSUD

A
  • hydration and rapid removal of the branched-chain amino acids
  • Hemodialysis: most effective
  • mannitol, diuretics: if cerebral edema (+)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  • All forms are inherited as an autosomal recessive trait
  • Mutations in genes for Ela (45%) and E18 (35%) account for approximately 80% of cases
  • the infant may be quite sick by the time the results of the screening becomes available
A

MSUD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
  • Inherited as autosomal recessive traits
  • Prenatal diagnosis
    > Is possible using specific genetic probes in cells obtained from biopsy of the chorionic villi
  • Unpleasant odor of phenylacetic acid, which has been described as musty or mousey
A

Classic Phenylketonuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
  • Very high plasma concentrations (>20 mg/dL or >1,200 pmole/L)
  • Plasma concentrations >20 mg/dL, excess phenylalanine is metabolized to phenylketones (phenylpyruvate and phenylacetate) that are excreted in the urine
  • Their presence in the body fluids simply signifies the severity of the condition
A

Classic phenylketonuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Mildly elevated levels (2-10 mg/dL or 120-600 pmole/L)

A

Mild hyperphenylalaninemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  • (plasma phenylalanine levels >20 mg/dL)
  • Affected infant is normal at birth
  • Profound intellectual disability develops gradually if the infant remains untreated
  • In untreated patients
    > 50-70% will have an IQ below 35, and 88-90% will have an IQ below 65
    > Only 2-5% of untreated patients will have normal intelligence
    > Older untreated children become hyperactive
    with autistic behaviors, including purposeless hand movements, rhythmic rocking, and athetosis
    > Microcephaly, prominent maxillae with widely spaced teeth, enamel hypoplasia, and growth retardation
A

Severe hyperphenylalaninemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

blood for screening for PKU be obtained in the

A

first 24-48 hr of life after feeding protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

PKU is confirmed by measurement of

A

plasma phenylalanine concentration (may rise 4hr after birth)

17
Q

Mainstay of treatment of PKU is

A

low-phenylalanine diet

  • Maintenance of lower plasma phenylalanine levels (2-10 mg/dL) has been strongly encouraged even after 12 yrs of age.
18
Q
  • denotes the elevated level of galactose in the blood
  • Two forms of the deficiency exist:
    > infants with complete or near complete deficiency of the enzyme (classic)
    > partial transferase deficiency
A

Galactosemia

19
Q
  • onset of symptoms typically by the second half of the 1st wk of life.
  • incidence is predicted to be 1 in 60,000 live births
  • newborn infant receives high amounts of lactose (up to 40% in breast milk and certain formulas), which consists of equal parts of glucose and galactose
A

Classic galactosemia

20
Q
  • unable to metabolize galactose-1-phosphate
  • the accumulation of which results in injury to kidney, liver, and brain
  • diagnosis considered in newborn or young infants with any of the following features:
    > Jaundice, hepatomegaly, vomiting, hypoglycemia, seizures, lethargy, irritability, feeding difficulties, poor weight gain or failure to regain birth weight, aminoaciduria, nuclear cataracts, vitreous hemorrhage, hepatic failure, liver cirrhosis, ascites, splenomegaly, or intellectual disability
  • Symptoms are milder and improve when milk is temporarily withdrawn and replaced by intravenous or lactose-free nutrition
  • Increased risk for Escherichia coli neonatal sepsis
    -Pseudotumor cerebri can occur and cause a bulging fontanel
  • Death from liver and kidney failure and sepsis may follow within days
  • When the diagnosis is not made at birth
    > damage to the liver (cirrhosis) and brain (intellectual disability) becomes increasingly severe and irreversible
A

Galactose-1-phosphate uridyl transferase deficiency galactosemia

21
Q
  • generally asymptomatic
  • diagnosed in newborn screening because of moderately elevated blood galactose and/or low transferase activity
  • considered for the newborn or young infant who is not thriving or who has any of the preceding findings
  • Light and electron microscopy of hepatic tissue
    > reveals fatty infiltration, the formation of pseudoacini, and eventual macronodular cirrhosis
A

Partial transferase deficiency G1PUTDG

22
Q

made by demonstrating a reducing substance in several urine specimens collected while the patient is receiving human milk, cow’s milk, or any other formula containing lactose

A

preliminary diagnosis of galactosemia

23
Q
  • Are usually negative
  • test materials rely on the action of glucose oxidase, which is specific for glucose and is nonreactive with galactose
A

Clinistix urine test results

24
Q
  • establishes the diagnosis
  • confirm that the patient did not receive a blood transfusion before the collection of the blood sample, as a diagnosis could be missed
A

Direct enzyme assay using erythrocytes

25
Q

accurately detect levels of galactose-1-phosphate uridyl transferase in erythrocytes

A

Nonradioactive UV and high-performance liquid
chromatography

26
Q

Tx for Galactosemia

A

Elimination of galactose from the diet along with adequate calcium supplementation

27
Q

is reported in 80% to more than 90% of female patients with classic galactosemia

A

Hypergonadotrophic hypogonadism

28
Q
  • principal metabolites accumulated are
    galactose and galactitol
  • Cataracts are usually the sole manifestation
  • pseudotumor cerebri is a rare complication
  • otherwise asymptomatic
  • Heterozygote carriers may be at risk for presenile cataracts
  • diagnosis is made by demonstrating an absence of galactokinase activity in erythrocytes or fibroblasts
  • Transferase activity is normal
  • Treatment is dietary restriction of galactose
A

Galactokinase Deficiency Galactosemia

29
Q
  • the most frequent disease involving enzymes of the hexose monophosphate pathway
  • responsible for 2 clinical syndromes:
    1. episodic hemolytic anemia
    2. chronic nonspherocytic hemolytic anemia
  • Most common manifestations
  • neonatal jaundice and episodic acute hemolytic anemia
  • induced by infections, certain drugs, and, rarely, fava beans
  • X-linked deficiency
A

G6PD Deficiency

30
Q
  • provides protection against oxidant threats from certain drugs and infections
  • otherwise cause precipitation of hemoglobin (Heinz bodies) or damage the RBC membrane
A

Reduced GSH

31
Q
  • Most cases of are not hereditary and result from thyroid dysgenesis
  • Most infants are detected by newborn screening
    programs in the 1st few wk after birth
  • before obvious clinical symptoms and signs develop
A

Congenital HYpothyroidism

32
Q
  • (aplasia, hypoplasia, or an ectopic gland) is the most common cause of permanent congenital hypothyroidism
  • accounting for 80-85% of cases
  • approximately 33% of cases of dysgenesis, even sensitive radionuclide scans can find no remnants of thyroid tissue (aplasia)
  • other 66% of infants, rudiments of thyroid tissue are found in an ectopic location, anywhere from the base of the tongue (lingual thyroid) to the normal position in the neck (hypoplasia)
  • 2:1female: male ratio
  • cause is unknown in most cases
  • occurs sporadically, but familial cases occasionally have been reporte
A

Thyroid Dysgenesis: Primary

33
Q
  • most common of the thyroxine (T4) synthetic defects
  • marked “discharge” of thyroid radioactivity when perchlorate or thiocyanate is administered 2 hr after administration of a test dose of radioiodine
A

Thyroid Peroxidase Defects of Organification and
Coupling

34
Q
  • autosomal recessive disorder
  • caused by a mutation in the chloride—iodide transport protein common to the thyroid gland and the cochlea
  • comprised of sensorineural deafness and goiter most common cause of syndromic deafness
  • mutation in the pendrin gene have impaired iodide
    organification and a positive perchlorate discharge
A

Pendred syndrome

35
Q
  • a family of autosomal recessive disorders of cortisol biosynthesis
  • Cortisol deficiency increases secretion of corticotropin (adrenocorticotropic hormone [ACTH]), which, in turn, leads to adrenocortical hyperplasia and overproduction of intermediate metabolites
A

COngenital Adrenal Hyperplasia

36
Q

affected fetuses by 8-10 wk of gestation and leads to
abnormal genital development | in females

A

Prenatal Androgen Excess (CAH)

37
Q

Blood levels of CAH

A

17-hydroxyprogesterone are markedly elevated

  • Diagnosis is most reliably established by measuring 17- hydroxyprogesterone before and 30 or 60 min after an intravenous bolus of 0.125-0.25 mg of cosyntropin (ACTH 1-24)
38
Q

Mothers with pregnancies at risk for CAH are given

A

dexamethasone, in an amount of 20 ug/kg
prepregnancy maternal weight daily in 2 or 3 divided doses